Upperton Pharma Solutions Raises over £4,000 for Children’s Charity, Rainbows Hospice
Upperton Pharma have raised over £4,000 for Rainbows, the children’s hospice serving families in Loughborough and across the East Midlands.
Sniffing Out Solutions in the Nasal Drug Delivery Revolution
The nose to brain pathway can be leveraged to unlock new therapeutic possibilities. Learn about the opportunities of N2B delivery.
What to Expect from Upperton at CPHI Frankfurt 2025
CPHI Frankfurt is one of the most anticipated events in the pharmaceutical calendar. Upperton is proud to be exhibiting.
The New Rules of CDMO Partnerships: What Biotechs Should Be Looking for Next
Biotech companies today seek long-term development partners who can help to de-risk supply chains, accelerate time-to-market.
The Bright Side of Biologic Stability: A Thermofluor Screen for Rational Buffer Optimisation
Learn about the challenges of stabilising injectable biologics.
Upperton wins Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025
Upperton wins the award for Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025.
Upperton Pharma Solutions Awarded VaxHub Sustainable Grant to Advance Oral Vaccine Delivery in Partnership with the University of Oxford’s Pandemic Sciences Institute
Upperton will apply its expertise to enable the next generation of Adenovirus-vectored vaccines to be delivered without needles.
Project Management Spotlight with Sophie Skinner
Discover more about our team. In this Spotlight, meet our Project Coordinator, Sophie Skinner, on her journey with Upperton.
Upperton Shortlisted for Two Categories at the Pharma Industry Awards UK 2025
We’re delighted to have been shortlisted in two major categories at the Pharma Industry Awards UK 2025, recognising our growth.
Biologics vs Small Molecules: Key Considerations in Drug Development
How the body absorbs, distributes, metabolizes, and excretes a drug – differs significantly between the two modalities.